Select content type to embed

All Research products

arrow_drop_down

<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://beta.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=inca________::24b45211a453b206be1edd7858ed46a5&type=result"></script>');
-->
</script>

COPY SCRIPT

For further information contact us at helpdesk@openaire.eu

COULD POSITRON EMISSION TOMOGRAPHY WITH RADIOLABELLED 3’-DEOXY-3’(18)F-FLUOROTHYMIDINE BE A THERANOSTIC TOOL DURING ERLOTINIB TREATMENT IN NON-SMALL CELL LUNG CANCER PATIENTS?

assignment_turned_inproject

Funder: Institut National du CancerProject code: INCa-DGOS-5631 Call for proposal: PHRC12

Funded under: PHRC

COULD POSITRON EMISSION TOMOGRAPHY WITH RADIOLABELLED 3’-DEOXY-3’(18)F-FLUOROTHYMIDINE BE A THERANOSTIC TOOL DURING ERLOTINIB TREATMENT IN NON-SMALL CELL LUNG CANCER PATIENTS?

- Summary
- DMPs

Partners

Hôpital Charles-Nicolle , Hôpital Larrey -CHU Toulouse , Hôpital Saint-Antoine , Hôpitaux de Brabois Adultes-Enfants , Hôpital Pellegrin , Hôpital d'Instruction des Armées (HIA) Percy , Centre Hospitalier Universitaire d'Angers , Hôpital Bretonneau , Hôpital Larrey -CHU Toulouse

Data Management Plans

Start a new DMP in Argos

Found an issue? Give us feedback

Select content type to embed

All Research products

arrow_drop_down

<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://beta.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=inca________::24b45211a453b206be1edd7858ed46a5&type=result"></script>');
-->
</script>

COPY SCRIPT

For further information contact us at helpdesk@openaire.eu

COULD POSITRON EMISSION TOMOGRAPHY WITH RADIOLABELLED 3’-DEOXY-3’(18)F-FLUOROTHYMIDINE BE A THERANOSTIC TOOL DURING ERLOTINIB TREATMENT IN NON-SMALL CELL LUNG CANCER PATIENTS?

COULD POSITRON EMISSION TOMOGRAPHY WITH RADIOLABELLED 3’-DEOXY-3’(18)F-FLUOROTHYMIDINE BE A THERANOSTIC TOOL DURING ERLOTINIB TREATMENT IN NON-SMALL CELL LUNG CANCER PATIENTS?

Loading